Protein aggregation and its inhibition in biopharmaceutics

International Journal of Pharmaceutics

Volumn 289, Issue 1-2, 2005, Pages 1-30

  Wang, Wei ^a,b  

^a Biotechnology Division   (United States)

^b PFIZER INC   (United States)

Author keywords

Aggregation mechanism; Protein aggregation; Protein formulation; Protein refolding; Protein stabilization

Indexed keywords

COMPUTER ANALYSIS; FREEZING; HEAT TREATMENT; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; THERMODYNAMICS;

BIOPHARMACEUTICS; CHEMISTRY, PHARMACEUTICAL; PROTEIN CONFORMATION;

EID: 11844291300     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.11.014     Document Type: Review

References (243)

1. S.J. Advant, and E.H. Braswell The effect of pH and temperature on the self-association of recombinant human interleukin-2 as studied by equilibrium sedimentation Pharm. Res. 12 1995 637 641
2. A.T. Alexandrescu, and K. Rathgeb-Szabo An NMR investigation of solution aggregation reactions preceding the misassembly of acid-denatured cold shock protein A into fibrils J. Mol. Biol. 291 1999 1191 1206
3. S.D. Allison, and A. Dong Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying, and rehydration Biophys. J. 71 1996 2022 2032
4. T.J. Anchordoquy, and J.F. Carpenter Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state Arch. Biochem. Biophys. 332 1996 231 238
5. J.D. Andya, and C.C. Hsu Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations AAPS Pharm. Sci. 5 2003 E10
6. J.D. Andya, and Y.F. Maa The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody Pharm. Res. 16 1999 350 358
7. R.K. Apenten Protein stability function relations: beta-lactoglobulin-A sulphydryl group reactivity and its relationship to protein unfolding stability Int. J. Biol. Macromol. 23 1998 19 25
8. T. Arakawa, and Y. Kita Protection of bovine serum albumin from aggregation by Tween 80 J. Pharm. Sci. 89 2000 646 651
9. T. Arakawa, and Y. Kita Protein-solvent interactions in pharmaceutical formulations Pharm. Res. 8 1991 285 291
10. T. Arakawa, and K. Tsumoto The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation Biochem. Biophys. Res. Commun. 304 2003 148 152
11. E. Assemand, and M. Lacroix l-Tyrosine prevents aggregation of therapeutic proteins by gamma-irradiation Biotechnol. Appl. Biochem. 38 2003 151 156
12. N.B. Bam, and J.L. Cleland Molten globule intermediate of recombinant human growth hormone: stabilization with surfactants Biotechnol. Prog. 12 1996 801 809
13. N.B. Bam, and J.L. Cleland Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions J. Pharm. Sci. 87 1998 1554 1559
14. N.B. Bam, and T.W. Randolph Stability of protein formulations: investigation of surfactant effects by a novel EPR spectroscopic technique Pharm. Res. 12 1995 2 11
15. B. Batas, and H.R. Jones Studies of the hydrodynamic volume changes that occur during refolding of lysozyme using size-exclusion chromatography J. Chromatogr. A 766 1997 109 119
16. M. Baudys, and T. Uchio Physical stabilization of insulin by glycosylation J. Pharm. Sci. 84 1995 28 33
17. A.M. Boctor, and S.C. Mehta Enhancement of the stability of thrombin by polyols: microcalorimetric studies J. Pharm. Pharmacol. 44 1992 600 603
18. D.R. Booth, and M. Sunde Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793
19. J. Brange, and L. Andersen Toward understanding insulin fibrillation J. Pharm. Sci. 86 1997 517 525
20. J. Brange, and S. Havelund Chemical stability of insulin. 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations Pharm. Res. 9 1992 727 734
21. E.D. Breen, and J.G. Curley Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation Pharm. Res. 18 2001 1345 1353
22. L. Bush, and C. Webb The formulation of recombinant factor IX: stability, robustness, and convenience Semin. Hematol. 35 1998 18 21
23. M. Calamai, and N. Taddei Relative influence of hydrophobicity and net charge in the aggregation of two homologous proteins Biochemistry 42 2003 15078 15083
24. M. Cardamone, and N.K. Puri Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies Biochemistry 34 1995 5773 5794
25. J.F. Carpenter, and J.H. Crowe An infrared spectroscopic study of the interactions of carbohydrates with dried proteins Biochemistry 28 1989 3916 3922
26. J.F. Carpenter, and J.H. Crowe Comparison of solute-induced protein stabilization in aqueous solution and in frozen and dried state J. Dairy Sci. 73 1990 3527 3636
27. J.F. Carpenter, and B.S. Kendrick Inhibition of stress-induced aggregation of protein therapeutics Methods Enzymol. 309 1999 236 255
28. J.F. Carpenter, and M.J. Pikal Rational design of stable lyophilized protein formulations: some practical advice Pharm. Res. 14 1997 969 975
29. I.J. Castellanos, and R. Crespo Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres J. Control Rel. 88 2003 135 145
30. B.S. Chang, and R.M. Beauvais Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation Arch. Biochem. Biophys. 331 1996 249 258
31. B.S. Chang, and B.S. Kendrick Surface-induced denaturation of proteins during freezing and its inhibition by surfactants J. Pharm. Sci. 85 1996 1325 1330
32. B.S. Chang, and G. Reeder Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist Pharm. Res. 13 1996 243 249
33. S.A. Charman, and K.L. Mason Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone Pharm. Res. 10 1993 954 962
34. B. Chen, and H.R. Costantino Influence of calcium ions on the structure and stability of recombinant human deoxyribonuclease I in the aqueous and lyophilized states J. Pharm. Sci. 88 1999 477 482
35. B.L. Chen, and T. Arakawa Aggregation pathway of recombinant human keratinocyte growth factor and its stabilization Pharm. Res. 11 1994 1581 1587
36. E.Y. Chi, and S. Krishnan Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation Pharm. Res. 20 2003 1325 1336
37. M. Cholewinski, and B. Luckel Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein. Calcitonine and human growth hormone in comparison Pharm. Acta Helv. 71 1996 405 419
38. B.A. Chrunyk, and R. Wetzel Breakdown in the relationship between thermal and thermodynamic stability in an interleukin-1 beta point mutant modified in a surface loop Protein Eng. 6 1993 733 738
39. E.D.B. Clark Refolding of recombinant proteins Curr. Opin. Biotechnol. 9 1998 157 163
40. A.R. Clarke, and J.P. Waltho Protein folding and intermediates Curr. Opin. Biotechnol. 8 1997 400 410
41. J.L. Cleland, and S.E. Builder Polyethylene glycol enhanced protein refolding Biotechnology (NY) 10 1992 1013 1019
42. J.L. Cleland, and D.I. Wang Refolding and aggregation of bovine carbonic anhydrase B: quasi-elastic light scattering analysis Biochemistry 29 1990 11072 11078
43. J.L. Cleland, and D.I. Wang Transient association of the first intermediate during the refolding of bovine carbonic anhydrase B Biotechnol. Prog. 8 1992 97 103
44. H.R. Costantino, and J.D. Andya Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody J. Pharm. Sci. 87 1998 1406 1411
45. H.R. Costantino, and L. Firouzabadian Protein spray-freeze drying. Effect of atomization conditions on particle size and stability Pharm. Res. 17 2000 1374 1383
46. H.R. Costantino, and K. Griebenow Fourier-transform infrared spectroscopic investigation of protein stability in the lyophilized form Biochim. Biophys. Acta 1253 1995 69 74
47. H.R. Costantino, and R. Langer Moisture-induced aggregation of lyophilized insulin Pharm. Res. 11 1994 21 29
48. H.R. Costantino, and R. Langer Solid-phase aggregation of proteins under pharmaceutically relevant conditions J. Pharm. Sci. 83 1994 1662 1669
49. H.R. Costantino, and R. Langer Aggregation of a lyophilized pharmaceutical protein, recombinant human albumin: effect of moisture and stabilization by excipients Biotechnology (NY) 13 1995 493 496
50. H.R. Costantino, and S.P. Schwendeman The secondary structure and aggregation of lyophilized tetanus toxoid J. Pharm. Sci. 85 1996 1290 1293
51. J.H. Crowe, and L.M. Crowe Preserving dry biomaterials: the water replacement hypothesis, part 2 Biopharm 6 1993 40 43
52. L. Curatolo, and B. Valsasina Recombinant human IL-2 is cytotoxic to oligodendrocytes after in vitro self-aggregation Cytokine 9 1997 734 739
53. L.G. Czaplewski, and J. McKeating Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants J. Biol. Chem. 274 1999 16077 16084
54. S. Damodaran, and K.B. Song Kinetics of adsorption of proteins at interfaces: role of protein conformation in diffusional adsorption Biochim. Biophys. Acta 954 1988 253 264
55. R.T. Darrington, and B.D. Anderson Evidence for a common intermediate in insulin deamidation and covalent dimer formation: effects of pH and aniline trapping in dilute acidic solutions J. Pharm. Sci. 84 1995 275 282
56. E. De Bernardez Clark, and E. Schwarz Inhibition of aggregation side reactions during in vitro protein folding Methods Enzymol. 309 1999 217 236
57. L.R. De Young, and K.A. Dill Aggregation and denaturation of apomyoglobin in aqueous urea solutions Biochemistry 32 1993 3877 3886
58. A. Dong, and B. Kendrick Spectroscopic study of secondary structure and thermal denaturation of recombinant human factor XIII in aqueous solution Arch. Biochem. Biophys. 347 1997 213 220
59. A. Dong, and S.J. Prestrelski Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation J. Pharm. Sci. 84 1995 415 424
60. S.D. Durbin, and G. Feher Protein crystallization Annu. Rev. Phys. Chem. 47 1996 171 204
61. G.A. Eberlein, and P.R. Stratton Stability of rhbFGF as determined by UV spectroscopic measurements of turbidity PDA J. Pharm. Sci. Technol. 48 1994 224 230
62. B.M. Eckhardt, and J.Q. Oeswein Effect of freezing on aggregation of human growth hormone Pharm. Res. 8 1991 1360 1364
63. H. Fabian, and K. Falber Secondary structure and oligomerization behavior of equilibrium unfolding intermediates of the lambda cro repressor Biochemistry 38 1999 5633 5642
64. B. Farruggia, and G. Garcia Destabilization of human serum albumin by polyethylene glycols studied by thermodynamical equilibrium and kinetic approaches Int. J. Biol. Macromol. 20 1997 43 51
65. A. Fatouros, and T. Osterberg Recombinant factor VIII SQ - influence of oxygen, metal ions, pH and ionic strength on its stability in aqueous solution Int. J. Pharm. 155 1997 121 131
66. F. Ferrone Analysis of protein aggregation kinetics Methods Enzymol. 309 1999 256 274
67. G. Fields, and D. Alonso Theory for the aggregation of proteins and copolymers J. Phys. Chem. 96 1992 3974 3981
68. A.L. Fink Protein aggregation: folding aggregates, inclusion bodies and amyloid Fold Des. 3 1998 R9 R23
69. J.M. Finke, and M. Roy Aggregation events occur prior to stable intermediate formation during refolding of interleukin 1beta Biochemistry 39 2000 575 583
70. K.C. Fox Biopreservation. Putting proteins under glass Science 267 1995 1922 1923
71. F. Franks Long-term stabilization of biologicals Biotechnology (NY) 12 1994 253 256
72. P.E. Fraser, and D.R. McLachlan Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues J. Mol. Biol. 244 1994 64 73
73. K.J. Frye, and C.A. Royer The kinetic basis for the stabilization of staphylococcal nuclease by xylose Protein Sci. 6 1997 789 793
74. W. Garzon-Rodriguez, and R.L. Koval Optimizing storage stability of lyophilized recombinant human interleukin-11 with disaccharide/hydroxyethyl starch mixtures J. Pharm. Sci. 93 2004 684 696
75. G. Georgiou, and P. Valax Isolating inclusion bodies from bacteria Methods Enzymol. 309 1999 48 58
76. G. Georgiou, and P. Valax Folding and aggregation of TEM beta-lactamase: analogies with the formation of inclusion bodies in Escherichia coli Protein Sci. 3 1994 1953 1960
77. C. Giancola, and C. De Sena DSC studies on bovine serum albumin denaturation. Effects of ionic strength and SDS concentration Int. J. Biol. Macromol. 20 1997 193 204
78. R. Golbik, and R. Zahn Thermodynamic stability and folding of GroEL minichaperones J. Mol. Biol. 276 1998 505 515
79. M. Gonzalez, and D.A. Murature Thermal stability of human immunoglobulins with sorbitol. A critical evaluation Vox. Sang. 68 1995 1 4
80. B.M. Gorovits, and P.M. Horowitz High hydrostatic pressure can reverse aggregation of protein folding intermediates and facilitate acquisition of native structure Biochemistry 37 1998 6132 6135
81. L.C. Gu, and E.A. Erdos Stability of interleukin 1 beta (IL-1 beta) in aqueous solution: analytical methods, kinetics, products, and solution formulation implications Pharm. Res. 8 1991 485 490
82. P. Gupta, and C.K. Hall Effect of denaturant and protein concentrations upon protein refolding and aggregation: a simple lattice model Protein Sci. 7 1998 2642 2652
83. T. Hagiwara, and H. Kumagai Fractal analysis of aggregates formed by heating dilute BSA solutions using light scattering methods Biosci. Biotechnol. Biochem. 60 1996 1757 1763
84. P. Hammarstrom, and M. Persson Structural mapping of an aggregation nucleation site in a molten globule intermediate J. Biol. Chem. 274 1999 32897 32903
85. L.R. Helms, and R. Wetzel Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis J. Mol. Biol. 257 1996 77 86
86. D. Hevehan, and E. De Bernardez-Clark Oxidative renaturation of lysozyme at high concentrations Biotechnol. Bioeng. 54 1997 221 230
87. K. Hinds, and J.J. Koh Synthesis and characterization of poly(ethylene glycol)-insulin conjugates Bioconjug. Chem. 11 2000 195 201
88. M.S. Hora, and R.K. Rana Lyophilized formulations of recombinant tumor necrosis factor Pharm. Res. 9 1992 33 36
89. M.S. Hora, and R.K. Rana Development of a lyophilized formulation of interleukin-2 Dev. Biol. Stand. 74 1992 295 303
90. C.C. Hsu, and H.M. Nguyen Surface denaturation at solid-void interface - a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures Pharm. Res. 12 1995 69 77
91. A.Y. Ip, and T. Arakawa Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization J. Pharm. Sci. 84 1995 1210 1214
92. S. Istrail, and R. Schwartz Lattice simulations of aggregation funnels for protein folding J. Comput. Biol. 6 1999 143 162
93. M. Jacob, and F.X. Schmid Protein folding as a diffusional process Biochemistry 38 1999 13773 13779
94. E.L. James, and S.P. Bottomley The mechanism of alpha 1-antitrypsin polymerization probed by fluorescence spectroscopy Arch. Biochem. Biophys. 356 1998 296 300
95. K. Janek, and J. Behlke Water-soluble beta-sheet models which self-assemble into fibrillar structures Biochemistry 38 1999 8246 8252
96. J.T. Jarrett, and P.T. Lansbury Jr. Amyoid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB Biochemistry 31 1993 12345 12352
97. G.M. Jordan, and S. Yoshioka The aggregation of bovine serum albumin in solution and in the solid state J. Pharm. Pharmacol. 46 1994 182 185
98. E. Kanaoka, and S. Nagata Stabilization of aerosolized IFN-gamma by liposomes Int. J. Pharm. 188 1999 165 172
99. N. Karuppiah, and A. Sharma Cyclodextrins as protein folding aids Biochem. Biophys. Res. Commun. 211 1995 60 66
100. M. Katakam, and A.K. Banga Aggregation of insulin and its prevention by carbohydrate excipients PDA J. Pharm. Sci. Technol. 49 1995 160 165
101. M. Katakam, and A.K. Banga Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses Pharm. Dev. Technol. 2 1997 143 149
102. M. Katakam, and L.N. Bell Effect of surfactants on the physical stability of recombinant human growth hormone J. Pharm. Sci. 84 1995 713 716
103. A. Kato, and T. Takagi Formation of intermolecular b-sheet structure during heat denaturation of ovalbumin J. Agric. Food Chem. 36 1988 1156 1159
104. B.S. Kendrick, and J.F. Carpenter A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma Proc. Natl. Acad. Sci. U.S.A. 95 1998 14142 14146
105. B.S. Kendrick, and B.S. Chang Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state Proc. Natl. Acad. Sci. U.S.A. 94 1997 11917 11922
106. B.S. Kendrick, and J.L. Cleland Aggregation of recombinant human interferon gamma: kinetics and structural transitions J. Pharm. Sci. 87 1998 1069 1076
107. B.A. Kerwin, and M.J. Akers Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications J. Pharm. Sci. 88 1999 79 88
108. B.A. Kerwin, and M.C. Heller Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20°C of a recombinant hemoglobin J. Pharm. Sci. 87 1998 1062 1068
109. M. Khossravi, and S.J. Shire Evidence for the involvement of histidine A(12) in the aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation Biochemistry 39 2000 5876 5885
110. R. Khurana, and J.R. Gillespie Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates Biochemistry 40 2001 3525 3535
111. D. Kim, and M.H. Yu Folding pathway of human alpha 1-antitrypsin: characterization of an intermediate that is active but prone to aggregation Biochem. Biophys. Res. Commun. 226 1996 378 384
112. J. King Refolding with a piece of the ring Nat. Biotechnol. 15 1997 514 515
113. Y. Kita, and T. Arakawa Salts and glycine increase reversibility and decrease aggregation during thermal unfolding of ribonuclease-A Biosci. Biotechnol. Biochem. 66 2002 880 882
114. J. Klein, and P. Dhurjati Protein aggregation kinetics in an Escherichia coli strain overexpressing a Salmonella typhimurium CheY mutant gene Appl. Environ. Microbiol. 61 1995 1220 1225
115. A. Knappik, and A. Plhckthun Engineered turns of a recombinant antibody improve its in vivo folding Protein Eng. 8 1995 81 89
116. W.D. Kohn, and C.M. Kay Salt effects on protein stability: two-stranded alpha-helical coiled-coils containing inter- or intrahelical ion pairs J. Mol. Biol. 267 1997 1039 1052
117. E.H. Koo, and P.T. Lansbury Jr. Amyloid diseases: abnormal protein aggregation in neurodegeneration Proc. Natl. Acad. Sci. U.S.A. 96 1999 9989 9990
118. L. Kreilgaard, and S. Frokjaer Effects of additives on the stability of recombinant human factor XIII during freeze-drying and storage in the dried solid Arch. Biochem. Biophys. 360 1998 121 134
119. L. Kreilgaard, and S. Frokjaer Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid J. Pharm. Sci. 88 1999 281 290
120. L. Kreilgaard, and L.S. Jones Effect of Tween 20 on freeze-thawing-and agitation-induced aggregation of recombinant human factor XIII J. Pharm. Sci. 87 1998 1597 1603
121. R. Krishnamurthy, and M.C. Manning The stability factor: importance in formulation development Curr. Pharm. Biotechnol. 3 2002 361 371
122. S. Krishnan, and E.Y. Chi Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition Biochemistry 41 2002 6422 6431
123. B. Kuhlman, and D.L. Luisi Global analysis of the effects of temperature and denaturant on the folding and unfolding kinetics of the N-terminal domain of the protein L9 J. Mol. Biol. 284 1998 1661 1670
124. B. Kuhlman, and H.Y. Yang An exceptionally stable helix from the ribosomal protein L9: implications for protein folding and stability J. Mol. Biol. 270 1997 640 647
125. I.V. Kurochkin, and R. Procyk Domain structure, stability and domain-domain interactions in recombinant factor XIII J. Mol. Biol. 248 1995 414 430
126. Y.M. Kwon, and M. Baudys In situ study of insulin aggregation induced by water-organic solvent interface Pharm. Res. 18 2001 1754 1759
127. N.D. Lazo, and D.T. Downing Beta-helical fibrils from a model peptide Biochem. Biophys. Res. Commun. 235 1997 675 679
128. F. Ledl, and J. Beck Chemical pathways of the Maillard reaction Prog. Clin. Biol. Res. 304 1989 23 42
129. S. Li, and T.H. Nguyen Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation Biochemistry 34 1995 5762 5772
130. J.N. Liang, and M.T. Rossi In vitro non-enzymatic glycation and formation of browning products in the bovine lens alpha-crystallin Exp. Eye Res. 50 1990 367 371
131. W.R. Liu, and R. Langer Moisture-induced aggregation of lyophilized proteins in the solid state Biotechnol. Bioeng. 37 1990 177 184
132. A. Lomakin, and G.B. Benedek Monitoring protein assembly using quasielastic light scattering spectroscopy Methods Enzymol. 309 1999 429 459
133. A. Lomakin, and D.B. Teplow Kinetic theory of fibrillogenesis of amyloid beta-protein Proc. Natl. Acad. Sci. U.S.A. 94 1997 7942 7947
134. B. Lueckel, and B. Helk Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage Pharm. Dev. Technol. 3 1998 337 346
135. R.L. Lundblad, and R.A. Bradshaw Applications of site-specific chemical modification in the manufacture of biopharmaceuticals Biotechnol. Appl. Biochem. 26 1997 143 151
136. Y.-F. Maa, and C.C. Hsu Protein denaturation by combined effect of shear and air-liquid interface Biotechnol. Bioeng. 54 1997
137. D.S. Maclean, and Q. Qian Stabilization of proteins by low molecular weight multi-ions J. Pharm. Sci. 91 2002 2220 2229
138. Y. Maeda, and T. Ueda Effective renaturation of denatured and reduced immunoglobulin G in vitro without assistance of chaperone Protein Eng. 9 1996 95 100
139. Y. Maeda, and H. Yamada Effect of additives on the renaturation of reduced lysozyme in the presence of 4 m urea Protein Eng. 9 1996 461 465
140. D.A. Malencik, and S.R. Anderson Dityrosine as a product of oxidative stress and fluorescent probe Amino Acids 25 2003 233 247
141. M.C. Manning, and J.E. Matsuura Approaches for increasing the solution stability of proteins Biotechnol. Bioeng. 48 1995 506 512
142. J. Matsuura, and M.C. Manning Conformation of human calcitonin gene-related peptide (8-37) in aqueous solution as determined by circular dichroism spectroscopy J. Pharm. Biomed. Anal. 11 1993 89 93
143. V.V. Mozhaev, and K. Martinek Structure-stability relationships in proteins: new approaches to stabilizing enzymes Enzyme Microb. Technol. 6 1984 50 59
144. K.P. Murphy, and V. Bhakuni Molecular basis of co-operativity in protein folding. III. Structural identification of folding units and folding intermediates J. Mol. Biol. 227 1992 293 306
145. L.O. Narhi, and J.S. Philo Reversibility of heat-induced denaturation of the recombinant human megakaryocyte growth and development factor Pharm. Res. 16 1999 799 807
146. D.P. Nesta, and J.S. Elliott Supercritical fluid precipitation of recombinant human immunoglobulin from aqueous solutions Biotechnol. Bioeng. 67 2000 457 464
147. H.D. Nguyen, and C.K. Hall Effect of rate of chemical or thermal renaturation on refolding and aggregation of a simple lattice protein Biotechnol. Bioeng. 80 2002 823 834
148. L.T. Nguyen, and J.M. Wiencek Characterization methods for the physical stability of biopharmaceuticals PDA J. Pharm. Sci. Technol. 57 2003 429 445
149. L. Nielsen, and S. Frokjaer Probing the mechanism of insulin fibril formation with insulin mutants Biochemistry 40 2001 8397 8409
150. L. Nielsen, and S. Frokjaer Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy J. Pharm. Sci. 90 2001 29 37
151. A. Oliva, and A. Santoveza Stability study of human serum albumin pharmaceutical preparations J. Pharm. Pharmacol. 51 1999 385 392
152. A. Parbhu, and H. Lin Imaging real-time aggregation of amyloid beta protein (1-42) by atomic force microscopy Peptides 23 2002 1265 1270
153. S.Y. Patro, and T.M. Przybycien Simulations of kinetically irreversible protein aggregate structure Biophys. J. 66 1994 1274 1289
154. R. Perlman, and T. Nguyen Pharmaceutics of protein drugs J. Pharm. Pharmcol. 44 1992 178 185
155. M.J. Pikal, and K.M. Dellerman The effects of formulation variables on the stability of freeze-dried human growth hormone Pharm. Res. 8 1991 427 436
156. E.M. Popov Protein folding as a nonlinear nonequilibrium thermodynamic process Biochem. Mol. Biol. Int. 47 1999 443 453
157. V. Prasanna, and B. Gopal Effect of amino acid substitutions at the subunit interface on the stability and aggregation properties of a dimeric protein: role of Arg 178 and Arg 218 at the Dimer interface of thymidylate synthase Proteins 34 1999 356 368
158. S.J. Prestrelski, and N. Tedeschi Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers Biophys. J. 65 1993 661 671
159. E. Querol, and J.A. Perez-Pons Analysis of protein conformational characteristics related to thermostability Protein Eng. 9 1996 265 271
160. B. Raman, and T. Ramakrishna Effect of the chaperone-like alpha-crystallin on the refolding of lysozyme and ribonuclease A FEBS Lett. 416 1997 369 372
161. R.V. Rariy, and A.M. Klibanov Correct protein folding in glycerol Proc. Natl. Acad. Sci. U.S.A. 94 1997 13520 13523
162. D. Renard, and J. Lefebvre Structural investigation of beta-lactoglobulin gelation in ethanol/water solutions Int. J. Biol. Macromol. 26 1999 35 44
163. J.P. Richards, and M.P. Stickelmeyer Self-association properties of monomeric insulin analogs under formulation conditions Pharm. Res. 15 1998 1434 1441
164. S.P. Roefs, and K.G. De Kruif A model for the denaturation and aggregation of beta-lactoglobulin Eur. J. Biochem. 226 1994 883 889
165. M.L. Roy, and M.J. Pikal The effects of formulation and moisture on the stability of a freeze-dried monoclonal antibody-vinca conjugate: a test of the WLF glass transition theory Dev. Biol. Stand. 74 1992 323 339 discussion 340
166. D. Rozema, and S.H. Gellman Artificial chaperone-assisted refolding of carbonic anhydrase B J. Biol. Chem. 271 1996 3478 3487
167. D. Rozema, and S.H. Gellman Artificial chaperone-assisted refolding of denatured-reduced lysozyme: modulation of the competition between renaturation and aggregation Biochemistry 35 1996 15760 15771
168. L. Runkel, and W. Meier Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta) Pharm. Res. 15 1998 641 649
169. J.A. Rupley, and G. Careri Protein hydration and function Adv. Protein Chem. 41 1991 37 172
170. Y. Sadhale, and J.C. Shah Stabilization of insulin against agitation-induced aggregation by the GMO cubic phase gel Int. J. Pharm. 191 1999 51 64
171. J. Safar, and P.P. Roller Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate Biochemistry 33 1994 8375 8383
172. H. Sah Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation J. Control Rel. 58 1999 143 151
173. S.U. Sane, and R. Wong Raman spectroscopic characterization of drying-induced structural changes in a therapeutic antibody: correlating structural changes with long-term stability J. Pharm. Sci. 93 2004 1005 1018
174. J.M. Sarciaux, and S. Mansour Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying J. Pharm. Sci. 88 1999 1354 1361
175. J.-M. Sarciaux, and S. Mansour Effect of species, processing conditions and phosphate buffer composition on IgG aggregation during lyophilization Pharm. Sci. (Suppl.) 1 1998 S-545
176. K. Sato, and A. Wakamiya Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid b(25-35) peptide as analyzed by single alanine substitution J. Biochem. (Tokyo) 118 1995 1108 1111
177. M.L. Scalley, and D. Baker Protein folding kinetics exhibit an Arrhenius temperature dependence when corrected for the temperature dependence of protein stability Proc. Natl. Acad. Sci. U.S.A. 94 1997 10636 10640
178. C.H. Schein Solubility as a function of protein structure and solvent components Biotechnology 8 1990 308 317
179. B. Schuler, and R. Rachel Formation of fibrous aggregates from a non-native intermediate: the isolated P22 tailspike beta-helix domain J. Biol. Chem. 274 1999 18589 18596
180. S.P. Schwendeman, and H.R. Costantino Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation Proc. Natl. Acad. Sci. U.S.A. 92 1995 11234 11238
181. S.P. Schwendeman, and H.R. Costantino Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine Dev. Biol. Stand. 87 1996 293 306
182. F. Separovic, and Y.H. Lam A solid-state NMR study of protein hydration and stability Pharm. Res. 15 1998 1816 1821
183. Z. Shahrokh, and G. Eberlein Major degradation products of basic fibroblast growth factor: detection of succinimide and iso-aspartate in place of aspartate Pharm. Res. 11 1994 936 944
184. Z. Shahrokh, and P.R. Stratton Approaches to analysis of aggregates and demonstrating mass balance in pharmaceutical protein (basic fibroblast growth factor) formulations J. Pharm. Sci. 83 1994 1645 1650
185. C.-L. Shen, and G.L. Scott Light scattering analysis of fibril growth from amino-terminal fragment b(1-28) of beta-amyloid peptide Biophys. J. 65 1993 2383 2395
186. V. Sluzky, and A.M. Klibanov Mechanism of insulin aggregation and stabilization in agitated aqueous solutions Biotechnol. Bioeng. 40 1992 895 903
187. V. Sluzky, and J.A. Tamada Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces Proc. Natl. Acad. Sci. U.S.A. 88 1991 9377 9381
188. A.V. Smith, and C.K. Hall Protein refolding versus aggregation: computer simulations on an intermediate-resolution protein model J. Mol. Biol. 312 2001 187 202
189. S. Soenderkaer, and J.F. Carpenter Effects of sucrose on rFVIIa aggregation and methionine oxidation Eur. J. Pharm. Sci. 21 2004 597 606
190. C. Soto, and E.M. Castano The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and is resistance to proteolysis Biochem. J. 314 1996 701 707
191. C. Soto, and E.M. Castano The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation J. Biol. Chem. 270 1995 3063 3067
192. C. Soto, and M.S. Kindy Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation Biochem. Biophys. Res. Commun. 226 1996 672 680
193. M.A. Speed, and J. King Polymerization mechanism of polypeptide chain aggregation Biotechnol. Bioeng. 54 1997 333 343
194. M. Stefani, and C.M. Dobson Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution J. Mol. Med. 81 2003 678 699
195. G. Stempfer, and B. Holl-Neugebauer Improved refolding of an immobilized fusion protein Nat. Biotechnol. 14 1996 329 334
196. D. Stigter, and K.D. Dill Theory for protein solubilities Fluid Phase Equilib. 82 1993 237 249
197. J. Stockel, and K. Doring Pathway of detergent-mediated and peptide ligand-mediated refolding of heterodimeric class II major histocompatibility complex (MHC) molecules Eur. J. Biochem. 248 1997 684 691
198. R.G. Strickley, and B.D. Anderson Solid-state stability of human insulin. II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: stabilization against covalent dimer formation J. Pharm. Sci. 86 1997 645 653
199. Z. Szabo, and E. Klement An FT-IR study of the beta-amyloid conformation: standardization of aggregation grade Biochem. Biophys. Res. Commun. 265 1999 297 300
200. C.M. Teschke Aggregation and assembly of phage P22 temperature-sensitive coat protein mutants in vitro mimic the in vivo phenotype Biochemistry 38 1999 2873 2881
201. J.G. Thomas, and A. Ayling Molecular chaperones, folding catalysts, and
202. S.N. Timasheff Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated Adv. Protein Chem. 51 1998 355 432
203. A. Tobitani, and S.B. Ross-Murphy Heat-induced gelation of globular proteins. 2. Effect of environmental factors on single-component and mixed-protein gels Macromolecules 30 1997 4855 4862
204. K. Tokihiro, and T. Irie Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution Chem. Pharm. Bull. (Tokyo) 45 1997 525 531
205. S.J. Tomski, and R.M. Murphy Kinetics of aggregation of synthetic b-amyloid peptide Arch. Biochem. Biophys. 294 1992 630 638
206. M.W. Townsend, and P.R. Byron The effects of formulation additives on the degradation of freeze-dried ribonuclease A Pharm. Res. 7 1990 1086 1091
207. M.J. Treuheit, and A.A. Kosky Inverse relationship of protein concentration and aggregation Pharm. Res. 19 2002 511 516
208. A.M. Tsai, and J.H. van Zanten I. Study of protein aggregation due to heat denaturation: a structural approach using circular dichroism spectroscopy, nuclear magnetic resonance, and static light scattering Biotechnol. Bioeng. 59 1998 273 280
209. A.M. Tsai, and J.H. van Zanten II. Electrostatic effect in the aggregation of heat-denatured RNase A and implications for protein additive design Biotechnol. Bioeng. 59 1998 281 285
210. P.K. Tsai, and D.B. Volkin Formulation design of acidic fibroblast growth factor Pharm. Res. 10 1993 649 659
211. +-ATPase from etiolated mung bean seedlings J. Protein Chem. 17 1998 161 172
212. K. Tsumoto, and M. Umetsu Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine Biochem. Biophys. Res. Commun. 312 2003 1383 1386
213. S.T. Tzannis, and S.J. Prestrelski Moisture effects on protein-excipient interactions in spray-dried powders. Nature of destabilizing effects of sucrose J. Pharm. Sci. 88 1999 360 370
214. V.N. Uversky, and A.S. Karnoup Association of partially-folded intermediates of staphylococcal nuclease induces structure and stability Protein Sci. 8 1999 161 173
215. B. van den Berg, and E.W. Chung The oxidative refolding of hen lysozyme and its catalysis by protein disulfide isomerase EMBO J. 18 1999 4794 4803
216. B. van den Berg, and R.J. Ellis Effects of macromolecular crowding on protein folding and aggregation EMBO J. 18 1999 6927 6933
217. S. Vemuri, and C.T. Yu Formulation and stability of recombinant alpha 1-antitrypsin Pharm. Biotechnol. 5 1993 263 286
218. A.W. Vermeer, and W. Norde The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein Biophys. J. 78 2000 394 404
219. D.B. Volkin, and A.M. Klibanov Minimizing protein inactivation T.E. Creighton Protein Function A Practical Approach 1989 Information Press Oxford, UK 1 24
220. D.B. Volkin, and C.R. Middaugh The characterization, stabilization, and formulation of acidic fibroblast growth factor Pharm. Biotechnol. 9 1996 181 217
221. D.B. Volkin, and P.K. Tsai Physical stabilization of acidic fibroblast growth factor by polyanions Arch. Biochem. Biophys. 300 1993 30 41
222. M. Vrkljan, and T.M. Foster Thermal stability of low molecular weight urokinase during heat treatment. II. Effect of polymeric additives Pharm. Res. 11 1994 1004 1008
223. J. Wall, and A. Solomon Flow cytometric characterization of amyloid fibrils Methods Enzymol. 309 1999 460 466
224. A. Wang, and A.D. Robertson Effects of a naturally occurring compatible osmolyte on the internal dynamics of ribonuclease A Biochemistry 34 1995 15096 150104
225. P.L. Wang, and T.P. Johnston Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407 J. Parenter. Sci. Technol. 47 1993 183 189
226. W. Wang Instability, stabilization, and formulation of liquid protein pharmaceuticals Int. J. Pharm. 185 1999 129 188
227. W. Wang Lyophilization and development of solid protein pharmaceuticals Int. J. Pharm. 203 2000 1 60
228. Y.J. Wang, and Z. Shahrokh Characterization, stability, and formulations of basic fibroblast growth factor Pharm. Biotechnol. 9 1996 141 180
229. S.D. Webb, and J.L. Cleland A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20 J. Pharm. Sci. 91 2002 543 558
230. S.D. Webb, and J.L. Cleland Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-gamma J. Pharm. Sci. 92 2003 715 729
231. S.D. Webb, and S.L. Golledge Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations J. Pharm. Sci. 91 2002 1474 1487
232. J. Wen, and T. Arakawa Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions Anal. Biochem. 240 1996 155 166
233. D.B. Wetlaufer, and Y. Xie Control of aggregation in protein refolding: a variety of surfactants promote renaturation of carbonic anhydrase II Protein Sci. 4 1995 1535 1543
234. R. Wetzel For protein misassembly, it's the "I" decade Cell 86 1996 699 702
235. C.M. Won, and T.E. Molnar Stabilizers against heat-induced aggregation of RPR, 114849, an acidic fibroblast growth factor (AFGF) Int. J. Pharm. 167 1998 25 36
236. Y. Xie, and D.B. Wetlaufer Control of aggregation in protein refolding: the temperature-leap tactic Protein Sci. 5 1996 517 523
237. M. Yasuda, and Y. Murakami Effect of additives on refolding of a denatured protein Biotechnol. Prog. 14 1998 601 616
238. J.M. Yon The specificity of protein aggregation [new; comment] Nat. Biotechnol. 14 1996 1231
239. S. Yoshioka, and Y. Aso Aggregates formed during storage of beta-galactosidase in solution and in the freeze-dried state Pharm. Res. 10 1993 687 691
240. S. Zarina, and H.R. Zhao Advanced glycation end products in human senile and diabetic cataractous lenses Mol. Cell Biochem. 210 2000 29 34
241. J. Zhang, and X. Peng NMR study of the cold, heat, and pressure unfolding of ribonuclease A Biochemistry 34 1995 8631 8641
242. M.Z. Zhang, and J. Wen A new strategy for enhancing the stability of lyophilized protein: the effect of the reconstitution medium on keratinocyte growth factor Pharm. Res. 12 1995 1447 1452
243. T. Zlateva, and R. Boteva Factors affecting the dissociation and aggregation of human interferon gamma Int. J. Biol. Macromol. 26 1999 357 362